Mykhailo Buchynskyi

Ternopil, 46001, Ukraine

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Six-month statin therapy and short-term MASLD progression: a prospective cohort study adjusted for abdominal obesity and glycemic control.

Six-month statin therapy and short-term MASLD progression: a prospective cohort study adjusted for abdominal obesity and glycemic control.

Journal: Scientific reports
Published: March 21, 2026

War, diet, and PTSD in Ukrainian youth.

War, diet, and PTSD in Ukrainian youth.

Journal: Scientific reports
Published: July 30, 2025

Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course.

Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course.

Journal: Journal of personalized medicine
Published: March 10, 2025

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease.

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease.

Journal: Frontiers in microbiology
Published: February 16, 2025

Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study.

Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study.

Journal: Frontiers in genetics
Published: July 05, 2024

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes.

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes.

Journal: Viruses
Published: May 15, 2024

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study.

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study.

Journal: Viruses
Published: December 15, 2023

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.

Journal: Viruses
Published: July 06, 2023

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.

Journal: Viruses
Published: April 01, 2023

Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience.

Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience.

Journal: International journal of molecular sciences
Published: February 27, 2023

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis.

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis.

Journal: Frontiers in immunology
Published: October 14, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026